Cargando…
Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness
BACKGROUND: Alemtuzumab induction therapy in kidney transplant patients results in T cell depletion followed by slow immune reconstitution of memory T cells with reduced immune functions. The kinetics and functional characteristics of T cell reconstitution when alemtuzumab is given during immune act...
Autores principales: | Bouvy, Anne P., Klepper, Mariska, Betjes, Michiel G.H., Weimar, Willem, Hesselink, Dennis A., Baan, Carla C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946521/ https://www.ncbi.nlm.nih.gov/pubmed/27500273 http://dx.doi.org/10.1097/TXD.0000000000000595 |
Ejemplares similares
-
Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms
por: de Graav, Gretchen N., et al.
Publicado: (2018) -
Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023) -
Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023) -
Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients
por: Laging, Mirjam, et al.
Publicado: (2019) -
Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)